Skyline Advisors
  • Home
  • Services
  • Team
  • Transactions
  • Industries
  • News
    • Firm News
    • Resources
    • Capital Markets
    • Food & Ag
    • Industrials
    • Technology
    • Healthcare
  • Contact
    • Newsletter

Partners for Strategic Transactions

FDA Recommends Approval of First Marijuana-Based Drug

4/20/2018

0 Comments

 
On Thursday, a Food and Drug Administration (FDA) advisory council recommended approval for an epilepsy drug that would be the first plant-derived cannabidiol medicine for prescription use in the US.
The drug, Epidiolex, was developed to treat severe, early onset epilepsy syndromes. The chemical derived from the marijuana plant, cannabidiol, in contrast to tetrahydrocannabinol (THC), does not produce a high to the user.

FDA approval would limit the drug’s use to patients who have epilepsy, though doctors would have the option to prescribe the drug off-label for other uses.

GW Pharmaceuticals, the maker of Epidiolex, said two experimental trials showed significant reductions in seizure types compared to patients taking placebos.

​The FDA is set to vote for the drug’s approval in June. 
0 Comments



Leave a Reply.

    Archives

    December 2018
    April 2018
    February 2018
    December 2017

    Categories

    All
    Healthcare
    Mergers And Acquisitions

    RSS Feed

about

Team
​Services
Transactions
Industries
​News
​Skyline Advisors is a division of Ideation Ventures, Inc. Services involving securities are offered through M&A Securities Group, Inc.  (“MAS”). Services involving real estate brokerage are offered through Berkshire Hathaway Homeservices Ambassador Real Estate ("BHHS"). Skyline, MAS, and BHHS are separate entities.
COPYRIGHT 2017. ALL RIGHTS RESERVED.
Subscribe to Newsletter
Virtual Data Room
Photo used under Creative Commons from inkknife_2000 (8.5 million views +)
  • Home
  • Services
  • Team
  • Transactions
  • Industries
  • News
    • Firm News
    • Resources
    • Capital Markets
    • Food & Ag
    • Industrials
    • Technology
    • Healthcare
  • Contact
    • Newsletter